BacTech Environmental Corporation
Raise of up to $600,000
The Offering:
Up to 12,000,000 Units priced at $0.05 per Unit
Each Unit consists of one Common Share and One Share Purchase Warrant
Each Share Purchase Warrant is exercisable into an additional Common Share at a price of $0.10 for 24 months from issuance
The Share Purchase Warrants are subject to an Acceleration Clause which shall take effect in the event that
the shares of the Company close at a trading price of CAD$0.20 per share or higher for 20 consecutive trading days, as indicated on the CSE Exchange, and
the Company shall have given notice by way of a press release that the Warrants’ expiry date will expire 10 trading days thereafter.
The Offering is available to accredited investors
Minimum order: 50,000 Units / $2,500
Securities issued under this Offering are subject to the standard 4 month hold period from the date of issuance
Securities issued under this Offering are RRSP / TFSA eligible
About the Company:
BacTech Environmental Corporation (“BacTech”) is a proven environmental technology company, delivering effective and eco-friendly bioleaching and remediation solutions to commercial operations to process and recover preferred metals (gold, silver, cobalt and copper) and safely remove and transform harmful contaminants like arsenic into benign EPA-approved products for landfill. Tapping into numerous environmental and economic advantages of its proprietary method of bioleaching, BacTech uses naturally occurring bacteria, harmless to both humans and the environment, to neutralize toxic mining sites with high-pay potential.
BacTech’s bioleaching process liberates precious and base metals from difficult to treat and generally harmful ores, concentrates, and tailings. BacTech's environmentally friendly processing benefits extend beyond the remediation of tailings and other mining stockpiles. Their solution strikes balance and considers benefits towards the planet, people, and profit.
BacTech plans to build a new owner-operated bioleaching facility near Ponce Enriquez, Ecuador, in a region where arsenic is associated with gold ore (Arsenopyrite). The Company plans to build a 50 tpd bioleaching plant to treat high gold/arsenic material. A 50 tpd plant, processing 1.95 ounces of gold per tonne of feed, similar to feeds available to the Company from local miners, would produce approximately 30,900 ounces per year. Plant designs are modular and can be expanded without affecting ongoing production. The total concentrate market in the Ponce Enriquez area is estimated to be between 200 and 250 tonnes per day, allowing for increased potential with a larger plant.
Click here to view the BacTech Website
Click here to view the BacTech Presentation
Investment Highlights
The Bankable Feasibility Study (BFS) on BacTech’s Tenguel, Ecuador bioleach facility, conducted by an independent third-party engineering group, and filed by BacTech on SedarPlus, used US$1,600 per ounce for gold and US$18 per ounce for silver in its financial modeling. The study projected a profit of US$11 million at US$1,600 gold. The project has a US$20 million capital cost to build the facility. With the price of gold reaching a new high, breaking through US$2,800 per ounce (as of the date hereof), the rate of return on capital becomes even more attractive.
Additionally, BacTech is preparing to file a final patent for the bioleaching of pyrrhotite tailings and run-of-mill production. The Company’s goal is to achieve zero waste from one (1) tonne of pyrrhotite material. Beyond producing nickel, cobalt, and copper, the technology aims to generate Iron suitable for sale to the steel and/or battery industries and Organic fertilizer utilizing the contained sulfur.
Exchange: CSE
Symbol: BAC
(ALSO: OTCBB: BCCEF, FSA: 0BT1)
Use of Proceeds:
Funds will be used for general working capital before securing financing for BacTech’s Tenguel, Ecuador bioleach facility.
Corporate Structure:
Recent Corporate News:
March 31, 2025
BacTech Announces Second Closing of Unit Financing
March 7, 2025
BacTech Closes First Tranche of Unit Financing
February 28, 2025
BacTech Announces Latest Capital Raise
November 25, 2024
BacTech Announces CBOE Approval of Royal Transaction with Silver Crown
October 25, 2024
BacTech Environmental Receives First Tranche of Silver Crown Royalties Shares
July 15, 2024
BacTech Secures Funding to Advance “Zero-Waste” Patent for Pyrrhotite
May 31, 2024
BacTech Signs Letter of Intent to Sell a Portion of its Annual Silver Production to Silver Crown
April 19, 2024
BacTech Environmental Corporation Appoints the President of Ecuador’s Chamber of Mines, Carolina Orozco, to Board of Directors
April 5, 2024
BacTech Environmental Unveils Intellectual Property for‘Zero-Waste’ Metals Recovery & Fertilizer Production
January 16, 2024
BacTech Provides a Follow-Up Update on Sudbury Pyrrhotite Tailings R&D Project
November 18, 2023
BacTech Environmental Receives Final ESIA Permit Approval from Ecuadorian Government to Begin Development of Bioleach Processing Facility in Tengu
BacTech in the News:
January 6, 2025, Streetwise Reports
Is Ecuador’s Environment Improving At All?
September 9, 2024, Triple Pundit
From the Petri Dish to the Mine - These Microbes Dissolve Minerals
May 9, 2024, Streetwise Reports
Green Tech CEO Says Ecuador Deal Good Sign for Troubled Country
November 27, 2023, Global Mining Review
BacTech Environmental Receives Approval for Bioleach Processing Facility in Ecuador
June 7, 2022, CBC News
Toronto company looks to extract billions in value from Sudbury mine waste
The Technology:
Conventional gravity/flotation to remove sulphides from ore/tailings to make high-grade gold/arsenic concentrate
Sulphides are the source of acid release but also contain the valuable metal to be recovered
Bioleaching of arsenopyrite (arsenic/sulphide ore) concentrates produced from mining and/or tailings
The technology is commercially proven
BacTech has “in-house” capacity for the design, construction and operation of the plant
It is a continuous process which is safe, easy to operate and flexible
Scalable in a short period of time and capable of processing a wide variety of low to high grade concentrates
PLEASE NOTE THAT MEMBERS OF ASCENTA ARE SHAREHOLDERS OF bactech AND/OR INTEND TO PARTICIPATE IN THIS OFFERING.
Please express your interest in participating in this financing and we will attempt to hold a position for you. Once you have been confirmed, we will provide you with a Subscription Agreement and Ascenta’s Know Your Client documentation.
This financing is intended to close at such time or times as the Company determines.
The Company has agreed to pay a finder’s fee of 8% cash and 8% compensation options for the financing.